Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma

NCT03159117 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Melanoma

Interventions

DRUG: PF-06688992

Sponsor

Memorial Sloan Kettering Cancer Center

Collaborators

[object Object]